Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastric and Gastroesophageal Junction Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00718913
What this trial is testing

Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric Cancer

Who this might be right for
Gastric Cancer
Hellenic Oncology Research Group 40
Large-scale testing (Phase 3)Study completedNCT04499924
What this trial is testing

Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaEsophageal Adenocarcinoma
Seagen Inc. 17
Testing effectiveness (Phase 2)Study completedNCT00040859
What this trial is testing

Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Alliance for Clinical Trials in Oncology 48
Early research (Phase 1)Study completedNCT01386346
What this trial is testing

Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer

Who this might be right for
Esophageal CancerMalignant Neoplasm of Cardio-esophageal Junction of Stomach
Weill Medical College of Cornell University 12
Large-scale testing (Phase 3)Study completedNCT03813784
What this trial is testing

A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Treatment With Camrelizumab Plus Apatinib Mesylate in Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJ) Without Prior Systemic Therapy

Who this might be right for
Gastric CancerGastroEsophageal Cancer
Jiangsu HengRui Medicine Co., Ltd. 885
Early research (Phase 1)Active Not RecruitingNCT03132922
What this trial is testing

MAGE-A4ᶜ¹º³²T for Multi-Tumor

Who this might be right for
Urinary Bladder CancerMelanomaHead and Neck Cancer+7 more
USWM CT, LLC 71
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06666166
What this trial is testing

SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer

Who this might be right for
Advanced Gastric CarcinomaAdvanced Gastroesophageal Junction AdenocarcinomaAdvanced Colorectal Cancer
Yunpeng Liu 28
Testing effectiveness (Phase 2)Study completedNCT01129310
What this trial is testing

First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer.

Who this might be right for
Gastrointestinal NeoplasmGastric Adenocarcinoma
AHS Cancer Control Alberta 47
Testing effectiveness (Phase 2)UnknownNCT05246982
What this trial is testing

HLX07+HLX10+Chemotherapy or HLX07 Monotherapy in Patients With Advanced Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ)
Shanghai Henlius Biotech 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07233850
What this trial is testing

A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers

Who this might be right for
Gastric/Gastroesophageal Junction AdenocarcinomaMetastatic Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
Shenyang Sunshine Pharmaceutical Co., LTD. 300
Testing effectiveness (Phase 2)UnknownNCT05395780
What this trial is testing

Evaluate the Safety and Efficacy of Max-40279-01 in Patients With Advanced Gastric Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
Maxinovel Pty., Ltd. 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06454435
What this trial is testing

Conversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric Cancer

Who this might be right for
Gastric CancerGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital 158
Testing effectiveness (Phase 2)Looking for participantsNCT06560528
What this trial is testing

Disitamab Vedotin Combined With Tislelizumab and Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Cancer With HER2 Overexpression

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital 40
Testing effectiveness (Phase 2)UnknownNCT02924909
What this trial is testing

Phase II Trial of Neoadjuvant Treatment and Minimal Invasive Surgery for Esophageal and GEJ Cancer

Who this might be right for
Esophageal CancerInduction Chemotherapy
Instituto Nacional de Cancer, Brazil 50
Testing effectiveness (Phase 2)UnknownNCT04555304
What this trial is testing

Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line Therapy

Who this might be right for
Gastric CancerGastroesophageal Cancer
Chengdu Kanghong Biotech Co., Ltd. 81
Large-scale testing (Phase 3)Looking for participantsNCT04447352
What this trial is testing

HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT)

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Krankenhaus Nordwest 200
Large-scale testing (Phase 3)UnknownNCT04435652
What this trial is testing

QL1604 Plus Nab-paclitaxel Versus Paclitaxel in Subjects With Advanced Gastric Cancer.

Who this might be right for
Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Qilu Pharmaceutical Co., Ltd. 492
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526
What this trial is testing

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Who this might be right for
Non Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more
OncoC4, Inc. 733
Testing effectiveness (Phase 2)WithdrawnNCT07283848
What this trial is testing

Zimberelimab + Domvanalimab in Gastroesophageal Adenocarcinoma

Who this might be right for
Adenocarcinoma StomachAdenocarcinoma Gastroesophageal Junction
Massachusetts General Hospital
Not applicableUnknownNCT06277908
What this trial is testing

Postoperative Morbidity and Mortality After Gastric Cancer Surgery

Who this might be right for
Gastric CancerSiewert Type III Adenocarcinoma of Esophagogastric JunctionStomach Cancer
P. Herzen Moscow Oncology Research Institute 700
Next Page